225 related articles for article (PubMed ID: 25850616)
21. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
Du JZ; Du XJ; Mao CQ; Wang J
J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
[TBL] [Abstract][Full Text] [Related]
22. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C
Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841
[TBL] [Abstract][Full Text] [Related]
23. Superparamagnetic hollow hybrid nanogels as a potential guidable vehicle system of stimuli-mediated MR imaging and multiple cancer therapeutics.
Chiang WH; Ho VT; Chen HH; Huang WC; Huang YF; Lin SC; Chern CS; Chiu HC
Langmuir; 2013 May; 29(21):6434-43. PubMed ID: 23627806
[TBL] [Abstract][Full Text] [Related]
24. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
[TBL] [Abstract][Full Text] [Related]
25. Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy.
Yang X; Grailer JJ; Pilla S; Steeber DA; Gong S
Bioconjug Chem; 2010 Mar; 21(3):496-504. PubMed ID: 20163170
[TBL] [Abstract][Full Text] [Related]
26. Improved fluorescence imaging and synergistic anticancer phototherapy of hydrosoluble gold nanoclusters assisted by a novel two-level mesoporous canal structured silica nanocarrier.
Yang Y; Wang S; Xu C; Xie A; Shen Y; Zhu M
Chem Commun (Camb); 2018 Mar; 54(22):2731-2734. PubMed ID: 29479592
[TBL] [Abstract][Full Text] [Related]
27. Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene.
Patil BR; Kang SY; Jung DH; Avaji PG; Jun YJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2020; 15():981-990. PubMed ID: 32103951
[TBL] [Abstract][Full Text] [Related]
28. Development of Multifunctional Polydopamine Nanoparticles As a Theranostic Nanoplatform against Cancer Cells.
Wang J; Guo Y; Hu J; Li W; Kang Y; Cao Y; Liu H
Langmuir; 2018 Aug; 34(32):9516-9524. PubMed ID: 30039972
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
30. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
Zhang S; Qian X; Zhang L; Peng W; Chen Y
Nanoscale; 2015 May; 7(17):7632-43. PubMed ID: 25785502
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor (EGF) fragment-guided anticancer theranostic particles for pH-responsive release of doxorubicin.
Kang MK; Mao W; Lee JB; Yoo HS
Int J Pharm; 2017 Mar; 519(1-2):104-112. PubMed ID: 28087384
[TBL] [Abstract][Full Text] [Related]
32. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
[TBL] [Abstract][Full Text] [Related]
33. A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.
Dong Y; Tu Y; Wang K; Xu C; Yuan Y; Wang J
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7168-7172. PubMed ID: 32003112
[TBL] [Abstract][Full Text] [Related]
34. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
35. Polymeric nanoparticles: the future of nanomedicine.
Banik BL; Fattahi P; Brown JL
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):271-99. PubMed ID: 26314803
[TBL] [Abstract][Full Text] [Related]
36. A novel design of a polynuclear co-delivery system for safe and efficient cancer therapy.
Xing L; Zhang JL; Zhou TJ; He YJ; Cui PF; Gong JH; Sun M; Lu JJ; Huang Z; Jin L; Jiang HL
Chem Commun (Camb); 2018 Aug; 54(63):8737-8740. PubMed ID: 30027958
[TBL] [Abstract][Full Text] [Related]
37. Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment.
Obinu A; Rassu G; Corona P; Maestri M; Riva F; Miele D; Giunchedi P; Gavini E
Colloids Surf B Biointerfaces; 2019 May; 177():520-528. PubMed ID: 30822627
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of paramagnetic cations-Loaded polydopamine nanoparticles.
Vega MA; Nieto C; Marcelo G; Martín Del Valle EM
Colloids Surf B Biointerfaces; 2018 Jul; 167():284-290. PubMed ID: 29679804
[TBL] [Abstract][Full Text] [Related]
39. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
40. Magnetic core-shell S-nitrosothiols nanoparticles as tumor dual-targeting theranostic platform.
Liu T; Zhang P; Huang X; Chi X; Li Z; Zhang Z; Guo DS; Yang X
Colloids Surf B Biointerfaces; 2019 Sep; 181():400-407. PubMed ID: 31174075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
